39 research outputs found

    Capacitated max-Batching with Interval Graph Compatibilities

    Get PDF
    We consider the problem of partitioning interval graphs into cliques of bounded size. Each interval has a weight, and the cost of a clique is the maximum weight of any interval in the clique. This natural graph problem can be interpreted as a batch scheduling problem. Solving an open question from [7, 4, 5], we show NP-hardness, even if the bound on the clique sizes is constant. Moreover, we give a PTAS based on a novel dynamic programming technique for this case.

    ALK2 inhibitors display beneficial effects in preclinical models of <i>ACVR1</i> mutant diffuse intrinsic pontine glioma.

    Get PDF
    Diffuse intrinsic pontine glioma (DIPG) is a lethal childhood brainstem tumour, with a quarter of patients harbouring somatic mutations in ACVR1, encoding the serine/threonine kinase ALK2. Despite being an amenable drug target, little has been done to-date to systematically evaluate the role of ACVR1 in DIPG, nor to screen currently available inhibitors in patient-derived tumour models. Here we show the dependence of DIPG cells on the mutant receptor, and the preclinical efficacy of two distinct chemotypes of ALK2 inhibitor in vitro and in vivo. We demonstrate the pyrazolo[1,5-a]pyrimidine LDN-193189 and the pyridine LDN-214117 to be orally bioavailable and well-tolerated, with good brain penetration. Treatment of immunodeprived mice bearing orthotopic xenografts of H3.3K27M, ACVR1R206H mutant HSJD-DIPG-007 cells with 25 mg/kg LDN-193189 or LDN-214117 for 28 days extended survival compared with vehicle controls. Development of ALK2 inhibitors with improved potency, selectivity and advantageous pharmacokinetic properties may play an important role in therapy for DIPG patients

    The chain-reentrant shop with the no-wait constraint

    No full text
    International audienc

    Preemptive Scheduling with jobs transportation

    No full text
    International audienc

    Assessment of daily MODIS snow cover products to monitor snow cover dynamics over the Moroccan Atlas mountain range

    No full text
    In semi-arid Mediterranean areas, the snow in the mountains represents an important source of water supply for many people living downstream. This study assessed the daily MODIS fractional snow-covered area (FSC) products over seven catchments with a mixed snow-rain hydrological regime, covering the Atlas chain in Morocco. For this purpose, more than 4760 daily MODIS tiles (MOD10A1 version 5) from September 2000 to June 2013 were processed, based on a spatio-temporal filtering algorithm aiming at reducing cloud coverage and the problem of discrimination between snow and cloud. The number of pixels identified as cloudy was reduced by 96% from 22.6% to 0.8%. In situ data from five snow stations were used to investigate the relative accuracy of MODE snow products. The overall accuracy is equal to 89% (with a 0.1 m. threshold for snow depth). The timing of the seasonal snow was also correctly detected with 11.4 days and 9.4 days of average errors with almost no bias for onset and ablation dates, respectively. The comparison of the FSC products to a series of 15 clear sky FORMOSAT-2 images at 8 m resolution in the Rheraya sub-basin near to Marrakech showed a good correlation of the two datasets (r = 0.97) and a reasonable negative bias of -27 km(2). Finally, the FSC products were analyzed through seasonal indicators including onset and melt-out dates, the Snow Cover Duration (SCD) and the maximum snow cover extent (SCAmax) at the catchment level: (1) the dynamic of the snow cover area is characterized by a very strong inter-annual signal with a variation coefficient of the SCAmax reaching 77%; (2) there is no evidence of a statistically significant long-term trend although results have pointed out that the SCD increased in February-March and, to a lesser extent, decreased in April-May for the 2000-2013 period. The study concludes that the daily MODIS product can be used with reasonable confidence to map snow cover in the South Mediterranean area despite difficult detection conditions

    Delayed <it>Plasmodium falciparum</it> clearance following artesunate-mefloquine combination therapy in Thailand, 1997–2007

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>There is concern that artesunate resistance is developing in Southeast Asia. The purpose of this study is to investigate the prevalence of parasitaemia in the few days following treatment with artesunate-mefloquine (AM), which is an indirect measure of decreased artesunate susceptibility.</p> <p>Methods</p> <p>This is a retrospective analysis of 31 therapeutic efficacy studies involving 1,327 patients treated with AM conducted by the Thai National Malaria Control Programme from 1997–2007.</p> <p>Results</p> <p>The prevalence of patients with parasitaemia on day 2 was higher in the east compared to the west (east: 20%, west: 9%, OR 2.47, 95% CI: 1.77, 3.45). In addition, the prevalence of day-2 parasitaemia increased over time (OR for each year = 1.10, 95% CI: 1.03, 1.19). After controlling for initial parasitaemia and age, year and region remained important determinants of day-2 parasitaemia (OR for region = 3.98, 95%CI 2.63, 6.00; OR for year = 1.28, 95%CI: 1.17, 1.39). The presence of parasitaemia on day 2 and day 3 were specific, but not sensitive predictors of treatment failure.</p> <p>Discussion</p> <p>Delayed resolution of parasitaemia after AM treatment increased in eastern Thailand between 1997 and 2007, which may be an early manifestation of decreased artesunate susceptibility. However, clinical and parasitological treatment failure after 28 days (which is related to both mefloquine and artesunate decreased susceptibility) is not changing over time. The presence of parasitaemia on day 2 is a poor indicator of AM 28-day treatment failure.</p
    corecore